Editorial Comment on Current Status and Future Perspective of Molecular Residual Disease Testing in Genitourinary Cancers

Documenti analoghi

• Editorial Comment to Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers
  di: Wataru Obara, et al.
  Pubblicazione: (2025)
• Current Status and Future Perspectives of Molecular Residual Disease Testing in Genitourinary Cancers
  di: Taigo Kato, et al.
  Pubblicazione: (2025)
• Editorial Comment on Bayesian Reanalysis of Enzalutamide Plus Androgen Deprivation Therapy in Japanese Patients With Metastatic Hormone‐Sensitive Prostate Cancer: A Methodological Complement to Frequentist Analysis From the ARCHES Trial
  di: Fumihiko Urabe
  Pubblicazione: (2025)
• Editorial Comment on Impact of Approach Routes in MRI ‐Ultrasound Fusion Prostate Biopsy on Postbiopsy Complications: A Propensity Score‐Matched Analysis
  di: Fumihiko Urabe
  Pubblicazione: (2025)
• Considerations on the Optimal Imaging for Prostate Cancer Diagnosis
  di: Fumihiko Urabe, et al.
  Pubblicazione: (2025)